Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Cetadiol

From Wikipedia, the free encyclopedia
Cetadiol
Clinical data
Other namesAndrost-5-ene-3β,16α-diol; 3β,16α-Dihydroxy-5-androstene
Routes of
administration
Oral
Identifiers
  • (3S,8S,9S,10R,13R,14S,16R)-10,13-Dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,16-diol
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H30O2
Molar mass290.447 g·mol−1
3D model (JSmol)
  • C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H](C2)O)CC=C4[C@@]3(CC[C@@H](C4)O)C
  • InChI=1S/C19H30O2/c1-18-7-6-16-15(17(18)10-14(21)11-18)4-3-12-9-13(20)5-8-19(12,16)2/h3,13-17,20-21H,4-11H2,1-2H3/t13-,14+,15+,16-,17-,18+,19-/m0/s1
  • Key:CVCDJRPXEWJAAY-UVSUZTNJSA-N

Cetadiol, also known as androst-5-ene-3β,16α-diol, is a drug described as a "steroid tranquilizer" which was briefly investigated as a treatment for alcoholism in the 1950s.[1][2][3][4][5] It is an androstane steroid and analogue of 5-androstenediol (androst-5-ene-3β,17β-diol) and 16α-hydroxy-DHEA (androst-5-ene-3β,16α-diol-17-one), but showed no androgenic or myotrophic activity in animal bioassays.[4] The drug was reported in 1956 and studied until 1958.[1]

Chemistry

[edit]

See also

[edit]

References

[edit]
  1. 1 2 Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 86–. ISBN 978-1-4757-2085-3.
  2. Negwer M, Scharnow HG (2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 1841. ISBN 978-3-527-30247-5.
  3. Lemere F (April 1957). "New steroid hormone tranquilizing agent (cetadiol)". The American Journal of Psychiatry. 113 (10): 930. doi:10.1176/ajp.113.10.930. PMID 13402989.
  4. 1 2 Campbell CH, Sleeper HG (April 1956). "Cetadiol (5-androstene-3 16-diol) in the treatment of hospitalized alcoholics". The American Journal of Psychiatry. 112 (10): 845. doi:10.1176/ajp.112.10.845. PMID 13302491.
  5. Wexler D, Leiderman PH, Mendelson J, Kubzansky P, Solomon P (April 1958). "The effect of cetadiol on delirium tremens, alcoholic hallucinosis, and alcohol withdrawal". The American Journal of Psychiatry. 114 (10): 935–936. doi:10.1176/ajp.114.10.935. PMID 13508929.